chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My son is 3 years and 10 months old born on 12/27/2004. He has been a healthy child till 11/1/08.  On 10/29/08 he had his first Flu Shot. Before giving the shot his blood test was done and everything was found to be normal.  On 11/1/08 when he woke up in the morning his nose was bleeding and i noticed some blood blisters inside his cheeks while brushing. We took him to our primary care physician there they did his blood test and found his platelets to be as low as 1 K . They asked us to take him to emergency.  In Hospital he was diagnosed ITP (Idiopathic Thrombocytopenic Purpura) .  On Admission he was presented with epistaxis, gingival bleeding and petechia (right side of neck and L upper arm). He was hemodynamically stable without active bleeding and was treated with WinRho 75mcg/kg x 1. on HD#2, his plt count droppeded from 5,000 to 3,000 and he had several purpuric lesions around lips, and multiple petichea on distal tongue, posterior pharynx, anterior neck, and proximal to L PIV. He had no change of MS. On HD#3,(11/03), Prednisone therapy was started at 2mg/kg PO x 1, followed by 1mg/kg PO BID On HD#4,(11/04), platelets were unchanged at 3,000. Doctor discharged him and asked to come back on Friday (11/07). He is advised to take orapred (15mg/5ml), 5ml PO BID for 7 days, on friday his platelets count didnot go up still showing 3000 he was admitted again on saturday but before giving any other treatment they did blood test again and it raised to 9000 Platelets, on saturday doctor gave hin IVIG and they suggested that they will do Bone marrow test as they suspect something else might have caused may not be ITP could be lukemia, they didi blood test on sunday and stared giving IVIG second dose his platelets were up by 19000 and on monday it reached to 66000, bone marrow result were negative they found nothing in that and discharged us on Monday.  and asked us to come for regular checkup.  12/31/08 Reviewed hospital medical records of 11/8-11/10/2008. FINAL DX: acute idiopathic thrombocytopenia purpura Records reveal patient experienced epistaxis, gingival bleeding, petechiae, oral intake reduced, UO decreased.  Seen by PCP & plts count 1.  Admitted & Heme/onc consult done.  Tx w/IVF, steroids & WinRho.  Improved & d/c to home on tapering steroids & heme/onc clinic f/u.  11/14/08 Reviewed PCP medical records of 10/29-11/01/2008. FINAL DX: thrombocytopenia Records reveal patient experienced bilateral tender enlarged cervical lymph nodes & reduced oral intake.  Dx w/lymphadenopathy.  RTC 11/1 w/nosebleed & bruise on inside cheeks.  Had recent URI.  Fever, skin rash, lethargic, vomiting.  Exam revealed petechiae on palate, inflammed nasal mucosa w/bloody drainage, cracked lips, petechiae on neck, ears & upper back.  Referred to hospital for admit.
I suffered several side effects after receiving both doses of the shingrix. These included: low grade fever, chills, muscle aches, shivering, headache and nausea
pt had tonic clonic muscular activity for approx 45sec;no hx of neuro problems in past;pt & MD question rxn to MMR;
Information has been received from a physician concerning a 14 year old female who on approximately 04-JUN-2007 was vaccinated with a 0.5 ml first dose of GARDASIL. On approximately 04-JUN-2007 the patient experienced "a huge amount of redness and swelling that was 4 inches in diameter around the injection site". The "patient was taking MOTRIN" and using "cold compresses" to reduce the swelling. The "patient is not receiving the last two dose in the series". Unspecified medical attention was sought. Subsequently, the patient recovered. Additional information has been requested.
they feel very sick; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of MALAISE (they feel very sick) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (they feel very sick). At the time of the report, MALAISE (they feel very sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitants and treatment drugs are provided.
pt recvd vax 9AUG95 & devel rubella synd, angioedema & urticaria & was hospitalized;@ the time of the report the pt's sxs persisted;addl details are being requested;
My arm was sore for a few days; I felt like I had the flu for the next day; This case was reported by a consumer via media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than a day after receiving Shingles vaccine, the patient experienced pain in arm and influenza like illness. On an unknown date, the outcome of the pain in arm and influenza like illness were recovered/resolved.   It was unknown if the reporter considered the pain in arm and influenza like illness to be related to Shingles vaccine.  Additional details were provided as follows:  The patient had reported the case for himself/herself. The age at vaccination was not reported. The patient's arm was sore for a few days and he/she felt like he/she had the flu for the next day, but was fine after that. The reporter mentioned that he/she beats shingles. The follow-up would be not possible, as no contact details were available.
Vaccinated for COVID-19 with Pfizer on 3/11/2021 and 4/16/2021, tested positive for Covid-19 by PCR on 5/12/2021. Entered emergency department with complaints of knee pain on 5/14/2021 (knee aspiration done 5/12/2021). Also noted to have Covid-19 pneumonia and hypoxemic respiratory failure and was admitted to hospital.
Arm soreness; Fever; could hardly move the arm; pain in the arm woke her up; This case was reported by a consumer and described the occurrence of pain in arm in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st August 2019, the patient received Shingrix. On 21st August 2019, less than a day after receiving Shingrix, the patient experienced pain in arm, fever, mobility decreased and sleep disturbance. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the pain in arm, fever, mobility decreased and sleep disturbance were unknown.   It was unknown if the reporter considered the pain in arm, fever, mobility decreased and sleep disturbance to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and her arm sore for the rest of the day.  That night of vaccination, pain in the arm woke her up and she had a fever and could hardly move the arm. She got up and took Tylenol and could go back to sleep.  The next day of vaccination, the fever continued until about mid-afternoon day after vaccination.  It then got much better. This case linked with US2019AMR206279, reported by same reporter.
Patient was brought here by her daughter for altered mental status.  She could only answer questions yes, no or okay.  The patient was in Hospital 8/17/2021 for dehydration and had similar presentation.  2 weeks prior she was in Hospital once again for urinary tract infection.
on day of injection approx 13 mins after injection RN was called to her car. She reported throat tightness, and dizziness 911 was called and pt was monitored until symptoms improved. Was not transported to ED. 2 days later developed a hive like rash and was seen at walk in clinic was treated with prednisone.
Papular blanching rash on back. 9/27/16, spread to arms, legs, face and abdomen. No difficulty breathing not itching.
Tongue numbness, throat tightness, difficulty swallowing. Evaluated by EMS, refused to be transport to nearest ER for further evaluation.
became increasingly fussy & approx 6 hrs p/vax had a high pitched cry lasting several hrs & was intermittent; no fever present;
Notified by parent on 2/26/01 that on 1/12/01, daughter admitted to hospital after found unconscious at home. Lyme and MS ruled out by Neuro MD. Dx'd with ADEM related to pt receiving flu vaccine. Abnormal gait; incontinence and no short term memory.
Patient began experiencing arm redness/swelling approximately the size of 2x2. Reaction started day 3 and increased daily. Patient taking OTC pain reliever and benadryl. States that it feels like a "bee sting."
After he got the 2nd dose started hearing seashell like sound, noticed that after each succeeding booster dose; This spontaneous case was reported by a patient and describes the occurrence of HYPOACUSIS (After he got the 2nd dose started hearing seashell like sound, noticed that after each succeeding booster dose) in an elderly male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     The patient's past medical history included Stapedectomy ((replacement of the stapes bone in the middle ear) on his left ear) in November 1998, Hearing loss, Tinnitus and Hearing disability (background noise he was hearing). Concomitant products included INFLUENZA VACCINE (FLU VACCINE VII) and VARICELLA ZOSTER VACCINE for an unknown indication.    On 29-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOACUSIS (After he got the 2nd dose started hearing seashell like sound, noticed that after each succeeding booster dose). At the time of the report, HYPOACUSIS (After he got the 2nd dose started hearing seashell like sound, noticed that after each succeeding booster dose) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   After the surgery, the symptoms disappeared and patient was good for about 22 to 24 years.  Patient received 1st dose of Moderna on 02-Mar-2021 (lot number 010A21A), 2nd dose on 30-Mar-2021 (lot number 008B21-2A0, 1st booster dose on 03-Nov-2021 (lot number - 058E21A) and 2nd booster dose on 14-Apr-2022 (lot number 046L21A).  Patient had flu shots every fall and updated Shingles vaccine (2 doses) within the last year but did not have the exact dates on record. Patient stated that he did not have any problems (related to the ear) before Mar2021. After patient got the 2nd dose of the Moderna Covid-19 vaccine (10-14 days approximately), he started hearing seashell-like sound which was different from the tinnitus which patient had before getting the operation. Patient went on to get 3 booster doses, the last one being the bivalent dose. Patient noticed that after each succeeding booster dose, the symptom only got worse. This symptom were present 24/7. Patient went to see the doctor who operated on him but since he was already semi-retired, referred the patient to another ear doctor. The patient was given 3 options, to get it operated again, to get a hearing air or do nothing.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-380937 (Patient Link).
IPC was informed that patient tested positive for COVID-19, specimen collected 10/1/21 (Thermofisher) at facility.  HCP works as a(n) Receiving Clerk in the Receiving Department.  HCP was vaccinated on 5/21/21 and 6/12/21 (Pfizer).  Last day of work was 9/29/21 0730 - 1600.  HCP reported that symptoms began on 9/29/21 with cold sweats and congestion. Symptoms persisted with additional loss of taste and smell on 10/2/21  HCP denies fever, chills, body aches, runny nose, sore throat, headache, fatigue, cough, dyspnea, difficulty breathing, chest pain, nausea, vomiting, abdominal pain, or diarrhea.  HCP denies contact with confirmed COVID positive in the community, staff, patients, or sick individuals. He states there is no direct patient contact just with staff who also wear eye protection and face mask. HCP denies participation in high-risk activities (eg. gathers, parties, nightclubs/bars, or weddings). He states he does not interact with coworkers outside of the work environment.   At work, HCP does report consistent surgical mask and eye protection.  HCP does not recall being in contact with any COVID+ patients or staff.  HCP mostly eats alone outside but occasionally eats in the breakroom with another coworker.  HCP lives with two other roommates, one of which works in the same department, while the other works for facility. Both are asymptomatic and are fully vaccinated. HCP did not feel comfortable disclosing the names of the individuals.
This spontaneous report was received from a physician and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 11-NOV-2021, the patient was vaccinated with improperly stored dose of hepatitis A vaccine, inactivated (VAQTA) lot # U004366, expiration date 01-OCT-2022 (dose, route of administration and anatomical location were not reported) for prophylaxis. Administered dose of hepatitis A vaccine, inactivated (VAQTA) experienced temperature excursion of 0.7 degrees Celsius for 2 hours. There was no previous excursion reported. No additional adverse event was reported. This is one of several reports received from the same reporter. Sender's Comments:  US-009507513-2112USA000817: US-009507513-2112USA000819: US-009507513-2112USA000818: US-009507513-2112USA000820: US-009507513-2112USA000821: US-009507513-2112USA000822: US-009507513-2112USA000823: US-009507513-2112USA000824: US-009507513-2112USA000825.
pt was vaxed 16AUG94 2PM, arm sore, 17AUG94 started feeling nauseated, vomiting, sore throat & diarrhea; completed form @ parents request via telephoe;
Pt complained that she trouble tasting food/discerning Flavors. Condition worsen and pt taken to ER on Wednesday due to facial drop/drooling for evaluation where she was diagnosed with Bells palsy.
I had a headache every day. My nose was running like water all the time. I had nausea every day. I had diarrhea. I was fatigued that would not go away. I contacted my doctor. She ordered blood work and a stool sample.
Update to date on COVID vaccines, admitted through ED for sepsis with multiple infection sites who tested detected for COVID.  Provider discharge summary below:  "Patient admitted for sepsis secondary to urinary tract infection, C difficile, and diverticulitis, on Zosyn and oral Vancocin.  Patient also presented with altered mental status thought to be secondary to sepsis.  Unfortunately throughout his stay this not improve. At  times his eyes were open and he showed recognition of his wife but other than being able to state his name and that his leg hurt he was not able to communicate further.  Kidney function was monitored throughout this day.  Unfortunately his creatinine continued to increase despite gentle rehydration with D5 W.  At one point his hemoglobin dropped below 7, the patient was given a unit of blood. HGB was stable after infusion.  Patient also thought to have aspiration pneumonia as seen with chest x-ray which showed bilateral hazy infiltrates, and felt that this Zosyn which he was already on a would be able to treat that.  He began having worsened difficulty breathing, ABG performed showed O2 sat 75%, pH 7.46, patient started on BiPAP.  On BiPAP his O2 stabilized.  Respiratory therapy tried several times to wean him off BiPAP but was unsuccessful.  Altered mental status and AKI continued to worsen despite our medical care.  Patient's family discussed with attending physician and they decided at that time that it would be in the patient's best interest to switch to comfort care and consult with hospice.  Comfort care initiated, antibiotics stopped, labs stopped, gentle fluids continued with morphine 3 mg PRN.  Hospice consulted and they took over care."
a rash on her left arm which warm; a rash on her left arm which was red and warm; ran a fever for 24 hours; achy wasn't as bad as she thought it would be; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (a rash on her left arm which warm), RASH ERYTHEMATOUS (a rash on her left arm which was red and warm), PYREXIA (ran a fever for 24 hours) and MYALGIA (achy wasn't as bad as she thought it would be) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (a rash on her left arm which warm), RASH ERYTHEMATOUS (a rash on her left arm which was red and warm), PYREXIA (ran a fever for 24 hours) and MYALGIA (achy wasn't as bad as she thought it would be). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. At the time of the report, FEELING HOT (a rash on her left arm which warm) and RASH ERYTHEMATOUS (a rash on her left arm which was red and warm) had resolved and PYREXIA (ran a fever for 24 hours) and MYALGIA (achy wasn't as bad as she thought it would be) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drug was not reported.   This case was linked to MOD-2021-262465 (Patient Link).
This case was reported by a other health professional via call center representative and described the occurrence of slu0like symptoms in a adult patient who received SHINGRIX. On an unknown date, the patient  received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experience flu-like symptoms. On an unknown date, the outcome of the flu-like symptoms was unknown. It was unknown if the reporter considered the flu-like symptoms to be related to SHINGRIX. Additional information was reported as follows: The case was reported by a pharmacy student. The age at vaccination was not reported. The reporting pharmacy student stated that one of the pharmacists wanted to ask him about the adverse effects with SHINGRIX. The patient had flu-like symptoms. They were not sure exactly because not everyone has reported symptoms directly to them. Reporting pharmacy student did not have patient information at time of chat. This case has been linked with cases US2018077588 and case US2018GSK084008, reported by the same reporter.
Patient complained of experiencing severe vomitting, darrhea, headache, nausea, aches and pains, dizziness and dehydration. All symptoms began on tuesday night (night of vaccination). Patient went to the hospital and was treated for dehydration and was released.
Patient was given ZOSTAVAX on May 22, 2009.  Developed Zoster from neck to wrist on June 8, 2009.
A report has been received from a Health Professional concerning an 8 month old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The fifty-one year old woman received FLUMIST QUADRIVALENT on 10-Oct-2013. The outcome of the event of fifty-one year old woman received FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
About one hour after receiving my vaccine, I began experiencing a vascular headache and vestibular issues with balance and walking. Swelling of lymph node. Also, began experiencing vertigo 4 days post injection. Also experienced slurred speech. Went to PCP on October 13th and she prescribed low dose beta blocker which I developed an allergy to. I have an ongoing issue following vaccines.
20 plus patients were administered vaccine that was expired on 22Sep2021; vaccine was initially in frozen storage condition and placed in the refrigerator; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (20 plus patients were administered vaccine that was expired on 22Sep2021) and PRODUCT STORAGE ERROR (vaccine was initially in frozen storage condition and placed in the refrigerator) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (20 plus patients were administered vaccine that was expired on 22Sep2021) and PRODUCT STORAGE ERROR (vaccine was initially in frozen storage condition and placed in the refrigerator). On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED (20 plus patients were administered vaccine that was expired on 22Sep2021) and PRODUCT STORAGE ERROR (vaccine was initially in frozen storage condition and placed in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not reported. Treatment medications was not reported.
pt recv vax & exp swelling, redness & warmth (rt upper arm discomfort down into forearm;Limited ROM secondary to pain;cellulitis secondary to vax;d/c from ER on ATB;
Pt has fever of 103-104 for 2 days. Diagnosed with otitis media, seen in office 2/1 9:20-10:30am - treated with Amoxil, also received 2nd influenza vaccine, has history of reactive airway disease. Pt presented on 2/1 at 14:30 to ER with 103 temp, febrile seizure lasting 7-8 minutes stiffening of extremities, eyes rolled upward. Pt received IM Rocephin for otitis media. Pt discharged from ER at 0045 2/2/2001, alert, nontoxic.
Right thigh 7cm redness and swelling central 3cm induration and pain from a right hip to knee, no fever. pt able to walk and run, no limp.
Pt states he received second dose of Pfizer COVID-19 vaccine on 4/27/21. Reports on 4/29/21 his ring and pinky finger of his left hand became painful. States if he rests them for a while, like during sleep, when he moves them again, the pain is rated 9/10. States with movement throughout the day, pain is rated 2-3/10. Reports he has not taken any medication to help the pain, denies significant impact on ADLs, but states that typing is difficult and painful and notices pain with grasping. Has not sought medical care. Discussed when to seek evaluation. States understanding.
Patient was reporting heavy rash and lots of pain, she said she had it for a few days after the vaccine. She said she never had a reaction before. She said it was a good portion of her arm. She did not say she went to the MD or not.
Screaming (inconsolable), diarrhea Review by ER Doctors believed it may be due to vaccine administration. Orders were to monitor.
Information has been received from a study concerning a patient (age and gender not reported) who was vaccinated with a dose of PROQUAD (date, dose, route not reported). It was reported that the patient died due to drowning (date not reported). This is one of several reports from the same source. Additional information has been requested.